EA200602202A1 - Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения - Google Patents

Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения

Info

Publication number
EA200602202A1
EA200602202A1 EA200602202A EA200602202A EA200602202A1 EA 200602202 A1 EA200602202 A1 EA 200602202A1 EA 200602202 A EA200602202 A EA 200602202A EA 200602202 A EA200602202 A EA 200602202A EA 200602202 A1 EA200602202 A1 EA 200602202A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ezetimib
receiving
pharmaceutical compositions
compositions containing
primary alcohols
Prior art date
Application number
EA200602202A
Other languages
English (en)
Other versions
EA010373B1 (ru
Inventor
Раджеш Джаин
Коур Чанд Джиндал
Сукхджит Сингх
Original Assignee
Панацея Биотек Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Панацея Биотек Лтд. filed Critical Панацея Биотек Лтд.
Publication of EA200602202A1 publication Critical patent/EA200602202A1/ru
Publication of EA010373B1 publication Critical patent/EA010373B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Представлены новая фармацевтическая композиция, содержащая смесь высших первичных алифатических спиртов из от 24 до 39 атомов углерода, по меньшей мере один другой органический компонент, выбранный из смол и пигментов, углеводородов, сложных эфиров, кетонов и альдегидов, и фенольных соединений, и эзетимиб, его соли, аналоги или их производные, необязательно, с фармацевтически приемлемыми вспомогательными веществами, и способ получения такой композиции. Также представлены способ лечения и использования такой композиции для снижения патологических липидных показателей, связанных с гиперлипидемией.
EA200602202A 2004-01-20 2005-01-19 Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения EA010373B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN103DE2004 2004-01-20
PCT/IN2005/000025 WO2005067903A1 (en) 2004-01-20 2005-01-19 Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof

Publications (2)

Publication Number Publication Date
EA200602202A1 true EA200602202A1 (ru) 2007-04-27
EA010373B1 EA010373B1 (ru) 2008-08-29

Family

ID=34779371

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602202A EA010373B1 (ru) 2004-01-20 2005-01-19 Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения

Country Status (9)

Country Link
US (1) US20070027218A1 (ru)
EP (1) EP1755573A1 (ru)
AP (1) AP2006003832A0 (ru)
AU (1) AU2005205166B8 (ru)
CA (1) CA2553985A1 (ru)
EA (1) EA010373B1 (ru)
RS (1) RS20060437A (ru)
WO (1) WO2005067903A1 (ru)
ZA (1) ZA200609584B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
SA04250427A (ar) 2003-12-23 2005-12-03 استرازينيكا ايه بي مشتقات ثاني فينيل أزيتيدون
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
BRPI0708556A2 (pt) * 2006-03-06 2011-05-31 Teva Pharma composição de ezetimiba
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
CN101190873B (zh) * 2006-11-24 2010-09-29 樊献俄 三十烷醇的制备方法
WO2008061428A1 (fr) * 2006-11-24 2008-05-29 Fan Xian E Formulations pharmaceutiques, utilisation et élaboration du triacontanol
WO2009158328A1 (en) * 2008-06-23 2009-12-30 Trustees Of The University Of Pennsylvania Method for in vivo measurement of reverse cholesterol transport
EP2216016A1 (en) * 2009-02-06 2010-08-11 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising ezetimibe
EP2468258A1 (en) * 2010-12-22 2012-06-27 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
CN104940153A (zh) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 一种治疗高血脂症的药物依折麦布组合物片剂
CN104958261A (zh) * 2015-08-05 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗心脑血管疾病的药物依折麦布组合物干混悬剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623667A (en) * 1985-06-28 1986-11-18 Richardson-Vicks Inc. Topical treatment of skin inflammatory disorders
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
US6225354B1 (en) * 1999-06-21 2001-05-01 Cholesterol Control Laboratories, Inc. High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
US6596776B2 (en) * 1999-06-21 2003-07-22 Hauser, Inc. High molecular weight primary aliphatic alcohols obtained from natural products and uses thereof
ATE337782T1 (de) * 2000-08-17 2006-09-15 Merck & Co Inc Cyclopentylmodulatoren der chemokin-rezeptor- aktivität
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
WO2003103632A1 (en) * 2002-06-10 2003-12-18 Elan Pharma International, Ltd. Nanoparticulate polycosanol formulations and novel polycosanol combinations

Also Published As

Publication number Publication date
AU2005205166B8 (en) 2008-04-24
US20070027218A1 (en) 2007-02-01
WO2005067903A8 (en) 2005-11-03
AU2005205166A1 (en) 2005-07-28
AU2005205166B2 (en) 2008-04-03
WO2005067903A1 (en) 2005-07-28
EP1755573A1 (en) 2007-02-28
CA2553985A1 (en) 2005-07-28
RS20060437A (en) 2008-11-28
EA010373B1 (ru) 2008-08-29
AP2006003832A0 (en) 2006-12-31
ZA200609584B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
EA200602202A1 (ru) Фармацевтические композиции, содержащие высшие первичные спирты и эзетимиб, и способ их получения
RU2391346C2 (ru) 39-дезметокси производные рапамицина
AU2014264103B2 (en) Phenol derivative and preparation method and use in medicine thereof
UA99361C2 (ru) ТРИАЗИНЫ КАК ИНГИБИТОРЫ PI3-КИНАЗЫ I mtor
AU2018342751A1 (en) Selective P2X3 modulators
RU2007114290A (ru) Способы и композиции для лечения гиперлипидемии
RU99115750A (ru) Новые соединения с анальгезирующим действием
EA200500814A1 (ru) Производные пирролопиримидина
IL189156A (en) A bite-containing (theo-hydrazide-rich) preparation, a flake cation and a thickening additive, a method for making this lipophilate and the leophilizate
SG10201806714PA (en) C7-fluoro substituted tetracycline compounds
JP2007517846A5 (ru)
WO2010014613A3 (en) Treating various disorders using trkb agonists
PE20081368A1 (es) Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina
WO2007054776A3 (en) Stilbene like compounds as novel hdac inhibitors
EP2150550A4 (en) NOVEL CARBAMOYLOXY ARYL ALKANE ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING SAID COMPOUND
BR112012029033A2 (pt) compostos
EA200700611A1 (ru) Производные бетулинола в качестве противораковых агентов
BRPI0519152A2 (pt) composto ou um sal ou derivado Éster farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, formulaÇÕes para tratar osteoporose e psorÍase, uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo, e, composiÇço farmacÊutica
AR050043A1 (es) Metodos para mejorar la biodisponibilidad y composicion farmaceutica para trastornos cardiovasculares
AR042480A1 (es) Derivados de la quinazolina para el trtamiento del crecimiento celular anormal
BRPI0415109A (pt) compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda
EA200602201A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ВЫСШИЕ ПЕРВИЧНЫЕ АЛИФАТИЧЕСКИЕ СПИРТЫ И ИНГИБИТОР ГМГ-КоА-РЕДУКТАЗЫ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
RU2217422C2 (ru) Гидроксииндолы, их применение в качестве ингибиторов фосфодиэстеразы 4 и способ их получения
JP2015522541A (ja) （１Ｒ−ｔｒａｎｓ）−Ｎ−［［２−（２，３−ジヒドロ−４−ベンゾフラニル）シクロプロピル］メチル］プロパンアミドの代謝物
AR063469A1 (es) Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU